Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper

Vaccine

Volumn 28, Issue 1, 2009, Pages 132-139

  Chandran, Dev ^a   Shahana, Pallichera Vijayan ^a   Rani, Gudavelli Sudha ^a   Sugumar, Parthasarthy ^a   Shankar, Chinchkar Ramchandra ^a   Srinivasan, Villuppanoor Alwar ^a  

^a Indian Immunologicals Limited   (India)

Author keywords

CDV; CPV; Epitope presentation; Physalis mottle tymovirus; VLPs

Indexed keywords

ALUMINUM HYDROXIDE; EPITOPE; HYBRID PROTEIN; PROTEIN P35; THIOMERSAL; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; CENTRIFUGATION; CHIMERA; CONTROLLED STUDY; DOG; DOG DISEASE; DRUG FORMULATION; DRUG POTENCY; ELECTRON MICROSCOPY; ESCHERICHIA COLI; EXPERIMENT; FELINE PANLEUKOPENIA VIRUS; GUINEA PIG; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PURIFICATION; SEROLOGY; T LYMPHOCYTE; TYMOVIRUS; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS PURIFICATION; VIRUS TYPING; WILD TYPE;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CELL LINE; DISTEMPER; DISTEMPER VIRUS, CANINE; DOGS; EPITOPES, T-LYMPHOCYTE; GUINEA PIGS; HEMAGGLUTINATION INHIBITION TESTS; NEUTRALIZATION TESTS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, CANINE; RABBITS; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC; VIRAL FUSION PROTEINS; VIRAL VACCINES;

EID: 70849106448     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.093     Document Type: Article

References (41)

1. Appel M., Scott F.W., and Carmichael L.E. Isolation and immunization studies of a canine parvo-like virus from dogs with haemorrhagic enteritis. Vet Rec 105 (1979) 156-179
2. Langeveld J., Casal J.I., Osterhaus A.D.M., Corte's E., Swart R., Vela C., et al. First peptide vaccine providing protection against viral infection in the target animals: studies of canine parvovirus in dogs. J Virol 68 (1994) 4506-4513
3. Griot C., Vandevelde M., Schobesberger M., and Zurbriggen A. Canine distemper, a re-emerging morbillivirus with complex neuropathogenic mechanisms. Anim Health Res Rev 4 1 (2003) 1-10
4. Krakowka S. Mechanisms of in vitro immunosuppression in canine distemper virus infection. J Clin Lab Immunol 8 (1982) 187-196
5. Griffin D.E. Measles virus. In: Knipe D.M., Howley P.M., Griffin D.E., Martin M.A., Lamb R.A., Roizman B., and Straus S.E. (Eds). Fields virology. 4th ed. (2001), Lippincott Williams and Wilkins, Philadelphia, PA 1401-1441
6. Ghosh S., Walker J., and Jackson D.C. Identification of canine helper T-cell epitopes from the fusion protein of canine distemper virus. Immunology 104 (2001) 58-66
7. Winters W.D. Time dependent decreases of maternal canine virus antibodies in newborn pups. Vet Rec 108 (1981) 295-299
8. Scholthof H.B., Scholthof K.B., and Jackson A.O. Plant virus gene vectors for transient expression of foreign proteins in plants. Annu Rev Phytopathol 34 (1996) 299-323
9. Johnson J., Lin T., and Lomonossoff G. Presentation of heterologous peptides on plant viruses: genetics, structure and function. Annu Rev Phytopathol 35 (1997) 67-86
10. Dalsgaard K., Uttenthal A., Jones T.D., Xu F., Merryweather A., Hamilton W.D., et al. Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol 15 (1997) 248-252
11. McLain L., Durrani Z., Wisniewski L.A., Porta C., Lomonossoff G.P., and Dimmock N. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus. Vaccine 14 (1996) 799-810
12. Sastri M., Ramesh K., Gopinath K., Ranjith Kumar C.T., Jagath J.R., and Savithri H.S. Assembly of physalis mottle virus capsid protein in Escherichia coli and the role of amino and carboxy termini in the formation of the icosahedral particles. J Mol Biol 272 (1997) 541-552
13. Sastri M., Reddy S.D., Sri Krishna S., Murthy M.R.N., and Savithri H.S. Identification of a discrete intermediate in the assembly/disassembly of physalis mottle tymovirus through mutational analysis. J Mol Biol 289 (1999) 905-918
14. Jacob A.N.K., Murthy M.R.N., and Savithri H.S. Nucleotide sequence of the 3′ terminal region of belladonna mottle virus-Iowa (renamed as physalis mottle virus) RNA and an analysis of the relationships of tymovirual coat proteins. Arch Virol 123 (1993) 367-377
15. Langeveld J.P.M., Casal J.I., Vela C., Dalsgaard K., Smale S.H., Puijk W.C., et al. B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface. J Virol 67 (1993) 765-772
16. Sambrook J., Fritisch E.F., and Maniatis T. Molecular cloning: a laboratory manual (1989), Cold Spring Harbor Laboratory Press, New York
17. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 1 (1951) 265-275
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
19. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Acad Sci USA 76 (1979) 4350-4354
20. Pollock R.V.H., and Carmichael L.E. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J Am Vet Med Assoc 180 (1982) 37-42
21. Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmakol 162 (1931) 480-483
22. Christian G., Christian M., Pascal C., Lukas B., Riccardo W., Andreas Z., et al. Early DNA vaccination of puppies against canine distemper in the presence of maternally derived immunity. Vaccine 22 (2004) 650-654
23. Everest P., Griffiths P., and Dougan G. Live Salmonella vaccines as a route towards oral immunization. Biologicals 23 (1995) 119-124
24. Resnick D.A., Smith A.D., Geisler C., Zhang A., Arnold A., and Arnold G.F. Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIVl) V3 loop seroprevalence library induce neutralizing responses against HIV-1. J Virol 69 (1995) 2406-2411
25. Rose C.P., and Evans D. Poliovirus antigen chimeras. Trends Biotechnol 9 (1991) 415-421
26. Montgomery D.L., Donnelly J.J., Shiver W., Liu M.A., and Ulmer B. Protein expression in vivo by injection of polynucleotides. Curr Opin Biotechnol 5 (1994) 505-510
27. Alving C.R. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants. Immunobiology 187 (1993) 430-446
28. Hsu S.C., Schadeck E.B., Delmas A., Shaw M., and Steward M.W. Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunisation. Vaccine 14 (1996) 1159-1166
29. Reed R.C., Louis-Wileman V., Cosmai E.V., Fang S., Jue D.L., Wohlhueter R.M., et al. Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii. Vaccine 15 (1997) 482-488
30. Adams S.E., Dawson K.M., Gull K., Kingsman S.M., and Kingsman A.J. The expression of hybrid HIV virus-like particles in yeast. Nature 329 (1987) 68-70
31. Takehara K.D., Ireland, and Bishop D.H.L. Coexpression of the hepatitis B surface and core antigens using baculovirus multiple expression vectors. J Gen Virol 69 (1988) 2763-2777
32. Urakawa T., Ferguson M., Minor P.D., Cooper J., Sullivan M., Almond J.W., et al. Synthesis of immunogenic, but non-infectious, poliovirus particles using a baculovirus expression vector. J Gen Virol 70 (1989) 1453-1463
33. French T.J., Marshall J.J.A., and Roy P. Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins. J Virol 64 (1990) 5695-5700
34. Zuidema D., Schoten A., Usmany M., Maule A.J., Belsham G.J., Roosien J., et al. Expression of cauliflower mosaic virus gene I in insect cells using a novel polyhedrin-based baculovirus expression vector. J Gen Virol 71 (1990) 2201-2209
35. Redmond M.J., Ohmann H.B., Hughes H.P.A., Sabara M., Frenchick P.L., Attah Poku S.K., et al. Rotavirus particles function as immunological carriers for the delivery of peptide from infectious agents and endogenous proteins. Mol Immunol 28 (1991) 269-278
36. Canizares M.C., Nicholson L., and Lomonossoff G.P. Use of viral vectors for vaccine production in plants. Immunol Cell Biol 83 (2005) 263-270
37. Denis J., Majeau N., Acosta-Ramirez E., Savard C., Bedard M.C., Simard S., et al. Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization. Virology 363 (2007) 59-68
38. Chakauya E., Chikwamba R., and Rybicki E.P. Riding the tide of biopharming win Africa: considerations for risk assessment. South African J Sci 102 (2006) 284-288
39. Watson J., Koya V., Leppa S., and Daniell H. Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food/feed crop. Vaccine 22 (2004) 4374-4384
40. Masarapu H., Nagendrakumar S.B., Yamini R., Chandran D., Rajendra L., Thiagarajan D., et al. Chimeric tymovirus-like particles displaying foot-and-mouth disease virus non-structural protein epitopes and its use for detection of FMDV-NSP antibodies. Vaccine 25 (2007) 4784-4794
41. Chinchkar S.R., Mohana Subramanian B., Hanumantha Rao N., Rangarajan P.N., Thiagarajan D., and Srinivasan V.A. Analysis of VP2 gene sequences of canine parvovirus isolates in India. Arch Virol 151 9 (2006) 1881-1887